Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease

Affiliations

Balmiki Ray: Department of Psychiatry, Laboratory of Molecular Neurogenetics, Indiana University School of Medicine
Bryan Maloney: Department of Psychiatry, Laboratory of Molecular Neurogenetics, Indiana University School of Medicine
Kumar Sambamurti: Department of Neurosciences, Medical University of South Carolina
Hanuma K. Karnati: National Institute on Aging, Drug Design and Development Section
Peter T. Nelson: Sanders-Brown Center on Aging, University of Kentucky
Nigel H. Greig: National Institute on Aging, Drug Design and Development Section
Debomoy K. Lahiri: Department of Psychiatry, Laboratory of Molecular Neurogenetics, Indiana University School of Medicine

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

ISSN: 2158-3188 (Online)
Publisher: Nature Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
Website: http://www.nature.com/tp/index.html